COvid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): study protocol for a randomized controlled trial

COvid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): study protocol for a randomized controlled trial

Abstract Background With the lack of effective therapy, chemoprevention, and vaccination against SARS-CoV-2, focusing on the immediate repurposing of existing drugs gives hope of curbing the COVID-19 pandemic. A recent unbiased genomics-guided tracing of the SARS-CoV-2 targets in human cells identif...

Full description

Bibliographic Details
Main Authors: Cédric Annweiler, Mélinda Beaudenon, Jennifer Gautier, Romain Simon, Vincent Dubée, Justine Gonsard, Elsa Parot-Schinkel, on behalf of the COVIT-TRIAL study group
Format: Article
Language:English
Published: BMC 2020-12-01
Series:Trials
Subjects:
COVID-19
SARS-CoV-2
Vitamin D
Anti-inflammatory
Antiviral
Randomized controlled trial
Online Access:https://doi.org/10.1186/s13063-020-04928-5

Internet

https://doi.org/10.1186/s13063-020-04928-5

Similar Items